Overview

A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)

Status:
Not yet recruiting
Trial end date:
2023-12-11
Target enrollment:
Participant gender:
Summary
This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP385 in the treatment of adult participants with moderate to severe ET.
Phase:
Phase 2
Details
Lead Sponsor:
Jazz Pharmaceuticals